(Q35019772)

5 August 2017

title

Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels (English)

1 reference

5 August 2017

0 references

1 reference

Michael P Fay

13

0 references

Amy D. Klion

object named as

Amy D Klion

15

0 references

Thomas B Nutman

14

object named as

Thomas B Nutman

1 reference

Michel Emmanuel Coulibaly

5 August 2017

8

object named as

Michel E Coulibaly

1 reference

5 August 2017

Benoit Dembele

1

1 reference

5 August 2017

Yaya I Coulibaly

2

1 reference

5 August 2017

Housseini Dolo

3

1 reference

5 August 2017

Siaka Konate

4

1 reference

5 August 2017

Siaka Y Coulibaly

5

1 reference

5 August 2017

Dramane Sanogo

6

1 reference

5 August 2017

Lamine Soumaoro

7

1 reference

5 August 2017

Salif Seriba Doumbia

9

1 reference

5 August 2017

Abdallah A Diallo

10

1 reference

5 August 2017

Sekou F Traore

11

1 reference

5 August 2017

Adama Diaman Keita

12

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Clinical Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

51

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1229-1235

1 reference

Confidence intervals that match Fisher's exact or Blaker's exact tests

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Mansonella perstans: safety and efficacy of ivermectin alone, albendazole alone and the two drugs in combination

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

The global programme to eliminate lymphatic filariasis: health impact after 8 years

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

National mass drug administration costs for lymphatic filariasis elimination

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Mathematical modelling and the control of lymphatic filariasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Strategies and tools for the control/elimination of lymphatic filariasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Elimination of lymphatic filariasis in the Republic of Korea: an epidemiological survey of formerly endemic areas, 2002-2006.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Mass treatment to eliminate filariasis in Papua New Guinea

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Single doses of ivermectin 400 micrograms/kg-1: the most effective dosage in bancroftian filariasis.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106228

Meeting of the International Task Force for Disease Eradication--29 October 2008

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21039220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Confirmation of elimination of lymphatic filariasis by an IgG4 enzyme-linked immunosorbent assay with urine samples in Yongjia, Zhejiang Province and Gaoan, Jiangxi Province, People's Republic of China

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21039220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1086/657063

1 reference

5 August 2017

1 reference

5 August 2017

1 reference